Impress consumers with sincerity
Release time:
2020-08-14
impresses consumers with sincerity
working 34 years, of which 17 years as a salesperson. I remember when I first started working, our teacher was also a store manager and taught us that "medicine is a special commodity, which is related to people's health, so we should give priority to social interests and supplement the interests of enterprises, on the premise of meeting the interests of the people, make the enterprise bigger and stronger". This statement sounded very general at the time, but it took years of work to understand its meaning. We are opening a drugstore, not a tour doctor who shoots today and changes tomorrow. Opening a drugstore not only attracts customers, but also retains customers. If a drugstore has no repeat customers, its survival period is not in years, but only in months. There are more and more pharmacies nowadays, but the quality of the staff is uneven, and even more so, it is driven by high gross profit, regardless of the actual efficacy of the medication, how can such pharmacies last for a long time?
The salesperson's sincerity and sincerity to the customer is to be sincerely tempered and spiritually passed on. In 2010 , when a trip surnamed Gu ke came to grasp traditional Chinese medicine, he put forward requirements for the price and quality of traditional Chinese medicine. I introduced in detail the purchase channels and quality management of the company's drugs, objectively described the market situation of traditional Chinese medicine in Jinhua area, and gave him the greatest discount in price. When the customer saw what I said, he handed me the prescription. If the price is good, his prescription will cost 120 yuan after a discount, of which 100 yuan is occupied by the cannon mountain tortoise. Therefore, I suggest that he powder the cannon mountain tortoise, which can be reduced by more than half by swallowing, and the effect is no worse than that of decocting. The price is only over 10 yuan a pair. He thought it was reasonable. He said that he had been to many pharmacies before, but no one had mentioned it to him. He had been arrested for six months and had already spent about 10,000 yuan. Since this time, he has been looking for me to buy medicine. I have become his health consultant and treat him as a friend. In this way, I sincerely to him, he assured me.
In 2003 , Tailai fought a price war with the common people. During that time, more customers came to our store to copy the price than to buy medicine. Before leaving, they even satirized us a few words. One day, an old man with limited mobility came to copy the price, but he couldn't see clearly, so I came forward and said, "Grandpa, you can't see clearly, let me help you copy." I copied the cost price on the computer to him, thinking that I could not make a profit and do some sales. In this way, grandpa took the list to Thailand to buy medicine. As I expected, he came back empty-handed after a while, saying that our price was about the same as Tailai. He lived nearby and bought a few commonly used medicines here. I took the opportunity to say that if I live nearby, I just need to make a phone call and we will deliver it to my door and guarantee parity. In this way, grandpa also introduced his daughter, son-in-law and neighbors in the community, saying that we were sincere in doing business.
Sincerity and sincerity are the basic criteria for the survival of a pharmacy. The above examples have occurred in every store of our peak pharmacy, and it is precisely in this way that the overall image of the peak has been improved, and at the same time the benefits of our large pharmacy have been improved, and the peak spirit has been inherited and carried forward. (xu xijun)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31